Related Experiment Video
Updated: Jun 24, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
Unloading in cardiogenic shock: the rationale and current evidence
Lisa Besch1,2, Benedikt Schrage1,2
1Department of Cardiology, University Heart and Vascular Center Hamburg.
Current Opinion in Critical Care
|June 6, 2024
Summary
Left ventricular unloading using microaxial flow pumps (MFP) shows mortality benefits in cardiogenic shock. Further trials are needed to confirm the role of various unloading strategies in shock patients.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Critical Care Medicine
Background:
- Cardiogenic shock is a life-threatening condition characterized by the heart's inability to pump sufficient blood.
- Left ventricular (LV) pressure and workload are critical factors in cardiogenic shock pathophysiology.
Purpose of the Study:
- To review the rationale and current evidence for left ventricular unloading in cardiogenic shock.
- To evaluate the efficacy of different mechanical circulatory support devices for LV unloading.
Main Methods:
- Review of current literature and clinical trial data on LV unloading strategies.
- Analysis of outcomes associated with microaxial flow pumps (MFP), intra-aortic balloon pumps (IABP), and veno-arterial extracorporeal membrane oxygenation (va-ECMO).
Main Results:
- MFP demonstrated a mortality reduction in selected cardiogenic shock patients.
- Evidence for IABP in cardiogenic shock remains neutral.
- Concomitant use of MFP/IABP with va-ECMO may improve outcomes but requires further investigation due to limited data and potential complications.
Conclusions:
- Left ventricular unloading is a key therapeutic strategy in cardiogenic shock.
- MFP is supported by strong evidence for use in selected patients.
- Further randomized controlled trials are essential to define the optimal role of various LV unloading devices and strategies in the broader cardiogenic shock population.
Related Concept Videos
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:24Blood Pressure Imbalances and Circulatory Shock
769
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
769
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336